Benjamin Feodoroff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benjamin Feodoroff has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Seppo Sarna
Department of Public Health, University of Helsinki
3 shared publications Hilpi Rautelin
2 shared publicationsPatrik Ellström
2 shared publicationsA.R. Lauhio
Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital
1 shared publicationAnneli Lauhio
Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital
1 shared publicationCaroline P.A. de Haan
1 shared publication
Latest Publications
- Open Access
- 1 October 2013
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 19 (10) , 1653-1655
Clonal Distribution and Virulence ofCampylobacter jejuniIsolates in Blood
Campylobacter jejuni bacteria are highly diverse enteropathogens. Seventy-three C. jejuni isolates from blood collected in Finland were analyzed by multilocus sequence typing and serum resistance. Approximately half of the isolates belonged to the otherwise uncommon sequence type 677 clonal complex. Isolates of this clonal complex were more resistant than other isolates to human serum.
- 1 October 2013
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 19 (10) , 1653-1655
Open AccessClonal Distribution and Virulence ofCampylobacter jejuniIsolates in Blood
Campylobacter jejuni bacteria are highly diverse enteropathogens. Seventy-three C. jejuni isolates from blood collected in Finland were analyzed by multilocus sequence typing and serum resistance. Approximately half of the isolates belonged to the otherwise uncommon sequence type 677 clonal complex. Isolates of this clonal complex were more resistant than other isolates to human serum.
- Open Access
- 15 September 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 53 (8) , e99-e106
A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998-2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobactercoli bacteremia in Finland from 1998 through 2007. Bacterial species were identified by means of polymerase chain reaction analysis, and minimal inhibitory concentrations for ciprofloxacin, clindamycin, doxycycline, erythromycin, gentamicin, meropenem, and metronidazole were determined with an agar dilution method. Medical records and mortality data within 1 year after the bacteremic episode were reviewed. Results. The study included 76 patients (median age, 46 years), for whom bacterial isolates (C. jejuni in 73, C. coli in 3) and clinical information were available. Most patients (70%) had no significant underlying diseases. The majority (82%) of the isolates were susceptible for all antimicrobial agents tested. However, antimicrobial therapy seemed to have only a limited effect, because no differences could be detected between patients with appropriate empirical antimicrobial treatment and those with delayed appropriate, inappropriate, or no antimicrobial therapy, either in the duration of hospitalization (median, 4 days for both groups) or in attributable mortality. The outcome of the infection was severe in 4 patients infected with C. jejuni; 2 died within 30 days, spondylodiscitis developed in 1, and Guillain-Barré syndrome developed in 1. Conclusions. C. jejuni and C. coli bacteremia occurred mainly in moderately young individuals without severe underlying diseases. The bacterial isolates were predominantly susceptible to antimicrobial agents, and the outcome of the disease was typically good, regardless of appropriate or inappropriate antimicrobial treatment given in the hospital.
- 15 September 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 53 (8) , e99-e106
Open AccessA Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998-2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobactercoli bacteremia in Finland from 1998 through 2007. Bacterial species were identified by means of polymerase chain reaction analysis, and minimal inhibitory concentrations for ciprofloxacin, clindamycin, doxycycline, erythromycin, gentamicin, meropenem, and metronidazole were determined with an agar dilution method. Medical records and mortality data within 1 year after the bacteremic episode were reviewed. Results. The study included 76 patients (median age, 46 years), for whom bacterial isolates (C. jejuni in 73, C. coli in 3) and clinical information were available. Most patients (70%) had no significant underlying diseases. The majority (82%) of the isolates were susceptible for all antimicrobial agents tested. However, antimicrobial therapy seemed to have only a limited effect, because no differences could be detected between patients with appropriate empirical antimicrobial treatment and those with delayed appropriate, inappropriate, or no antimicrobial therapy, either in the duration of hospitalization (median, 4 days for both groups) or in attributable mortality. The outcome of the infection was severe in 4 patients infected with C. jejuni; 2 died within 30 days, spondylodiscitis developed in 1, and Guillain-Barré syndrome developed in 1. Conclusions. C. jejuni and C. coli bacteremia occurred mainly in moderately young individuals without severe underlying diseases. The bacterial isolates were predominantly susceptible to antimicrobial agents, and the outcome of the disease was typically good, regardless of appropriate or inappropriate antimicrobial treatment given in the hospital.
- Open Access
- 1 January 2010
- Published by Springer Nature in Gut Pathogens
- Vol. 2 (1) , 22
Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection
Campylobacter jejuni is a significant cause of bacterial enteritis worldwide. Very little is known about the pathogenicity mechanisms and virulence factors of this important enteropathogen. C. jejuni isolates from 166 Finnish patients, collected from July to December in 2006, were studied for the presence of putative virulence factors and susceptibility to antimicrobials. Isolates were tested for production of γ-glutamyltransferase (GGT) as well as the presence of genes ceuE, cgtB, ciaB, cj0486, pldA, virB11, wlaN, and the gene cluster cdtABC. Bacterial characteristics were compared to information on foreign travel history as well as information on the course and the symptoms of disease obtained from questionnaires returned by patients. Except for one domestic isolate, antimicrobial resistance was only detected in isolates of foreign origin. Univariate analyses showed association between bloody stools and both GGT production (p = 0.025) and the presence of cgtB (p = 0.034). Multivariate analysis verified that GGT production was more prevalent in domestic isolates (p < 0.0001), while the genes cj0486 (p < 0.0001) and ceuE (p < 0.0001) were associated with C. jejuni isolates of foreign origin. The results indicate that imported and domestic C. jejuni isolates differ significantly in several aspects from each other.
- 1 January 2010
- Published by Springer Nature in Gut Pathogens
- Vol. 2 (1) , 22
Open AccessCampylobacter jejuni isolates in Finnish patients differ according to the origin of infection
Campylobacter jejuni is a significant cause of bacterial enteritis worldwide. Very little is known about the pathogenicity mechanisms and virulence factors of this important enteropathogen. C. jejuni isolates from 166 Finnish patients, collected from July to December in 2006, were studied for the presence of putative virulence factors and susceptibility to antimicrobials. Isolates were tested for production of γ-glutamyltransferase (GGT) as well as the presence of genes ceuE, cgtB, ciaB, cj0486, pldA, virB11, wlaN, and the gene cluster cdtABC. Bacterial characteristics were compared to information on foreign travel history as well as information on the course and the symptoms of disease obtained from questionnaires returned by patients. Except for one domestic isolate, antimicrobial resistance was only detected in isolates of foreign origin. Univariate analyses showed association between bloody stools and both GGT production (p = 0.025) and the presence of cgtB (p = 0.034). Multivariate analysis verified that GGT production was more prevalent in domestic isolates (p < 0.0001), while the genes cj0486 (p < 0.0001) and ceuE (p < 0.0001) were associated with C. jejuni isolates of foreign origin. The results indicate that imported and domestic C. jejuni isolates differ significantly in several aspects from each other.
- Open Access
- 1 February 2009
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 15 (2) , 188-192
Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates
- 1 February 2009
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 15 (2) , 188-192
Open AccessSevere diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates